No Data
No Data
Third Rock Ventures Sells Shares in Tango Therapeutics Worth Over $700k
Bitcoin Miner Bitfarms, Frontier Communications, and More Stocks See Action From Activist Investors -- Barrons.com
H.C. Wainwright Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $13
Tango Therapeutics: A Buy Rating Amidst Competitive Advantages and Promising Market Valuation
Small U.S. Stocks Finish Mixed As Xencor Lead, Tango Therapeutics Lags
Piper Sandler Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $18
No Data
No Data